Literature DB >> 17526850

Effect of host fatty acid-binding protein and fatty acid uptake on growth of Chlamydia trachomatis L2.

Guqi Wang1, Frank Burczynski2, Judy Anderson3, Guangming Zhong1.   

Abstract

Chlamydia trachomatis is an obligate intracellular bacterium and acquires both building blocks and energy from host cells for growth. The fatty acid-binding protein (FABP) plays an important role in uptake of long-chain fatty acids (LCFA) and energy metabolism by eukaryotic cells. The roles of FABP and LCFA in chlamydial infection were evaluated. Infection of liver cells with chlamydial organisms promoted fatty acid uptake by the infected cells, suggesting that LCFA may benefit chlamydial growth. Introduction of FABP into the liver cells not only enhanced fatty acid uptake, but also increased chlamydial intravacuolar replication and maturation. The FABP-enhanced chlamydial intracellular growth was dependent on the host cell uptake of fatty acids. These results have demonstrated that C. trachomatis can productively infect liver cells and utilize FABP-transported LCFA for its own biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526850     DOI: 10.1099/mic.0.2006/003491-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  9 in total

1.  ApoB-containing lipoproteins promote infectivity of chlamydial species in human hepatoma cell line.

Authors:  Yuriy K Bashmakov; Nailia A Zigangirova; Alexander L Gintzburg; Petr A Bortsov; Ivan M Petyaev
Journal:  World J Hepatol       Date:  2010-02-27

2.  Chlamydia trachomatis Relies on Autonomous Phospholipid Synthesis for Membrane Biogenesis.

Authors:  Jiangwei Yao; Philip T Cherian; Matthew W Frank; Charles O Rock
Journal:  J Biol Chem       Date:  2015-05-20       Impact factor: 5.157

3.  Chlamydia trachomatis Scavenges Host Fatty Acids for Phospholipid Synthesis via an Acyl-Acyl Carrier Protein Synthetase.

Authors:  Jiangwei Yao; V Joshua Dodson; Matthew W Frank; Charles O Rock
Journal:  J Biol Chem       Date:  2015-07-20       Impact factor: 5.157

4.  Chlamydia trachomatis growth inhibition and restoration of LDL-receptor level in HepG2 cells treated with mevastatin.

Authors:  Yuriy K Bashmakov; Nailya A Zigangirova; Yulia P Pashko; Lidia N Kapotina; Ivan M Petyaev
Journal:  Comp Hepatol       Date:  2010-01-28

5.  Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole.

Authors:  Jordan L Cocchiaro; Yadunanda Kumar; Elizabeth R Fischer; Ted Hackstadt; Raphael H Valdivia
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-30       Impact factor: 11.205

6.  The Chlamydia trachomatis CT149 protein exhibits esterase activity in vitro and catalyzes cholesteryl ester hydrolysis when expressed in HeLa cells.

Authors:  Jan Peters; Vijaya Onguri; Satoru K Nishimoto; Tony N Marion; Gerald I Byrne
Journal:  Microbes Infect       Date:  2012-08-23       Impact factor: 2.700

7.  Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization.

Authors:  Carolyn J Broccardo; Spencer Mahaffey; John Schwarz; Lisa Wruck; Gloria David; Patrick M Schlievert; Nichole A Reisdorph; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2011-01       Impact factor: 10.793

Review 8.  Infections at the nexus of metabolic-associated fatty liver disease.

Authors:  Robim M Rodrigues; Tamara Vanhaecke; Joost Boeckmans; Matthias Rombaut; Thomas Demuyser; Baptist Declerck; Denis Piérard; Vera Rogiers; Joery De Kock; Luc Waumans; Koen Magerman; Reinoud Cartuyvels; Jean-Luc Rummens
Journal:  Arch Toxicol       Date:  2021-05-24       Impact factor: 5.153

9.  Chlamydia trachomatis growth and development requires the activity of host Long-chain Acyl-CoA Synthetases (ACSLs).

Authors:  Maria A Recuero-Checa; Manu Sharma; Constance Lau; Paul A Watkins; Charlotte A Gaydos; Deborah Dean
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.